ICP Versus Intracranial Compliance Guided Management in SAH
ICP Versus Intracranial Compliance Guided Management in SAH
The purpose of this study is to determine whether treatment guided also by ICP mean wave
 amplitude improves outcome compared to international standard care in patients with SAH.
In this study SAH-patients are randomized to treatment based on international standard care
 (ICP/CPP guided therapy) or intracranial compliance (ICP mean wave amplitude) guided therapy
 in addition to ICP/CPP guided therapy. Main outcome variables are survival and neurological
 outcome after 3 and 12 months.
Inclusion Criteria:

 -  Subarachnoid hemorrhage, acute

 -  Intracerebral pressure monitoring device inserted

 Exclusion criteria:

 -  No intracranial pressure monitoring

 -  Age < 18 years